Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

15.92
-0.0300-0.19%
Post-market: 16.360.4400+2.76%19:46 EDT
Volume:1.21M
Turnover:19.30M
Market Cap:1.85B
PE:-12.17
High:16.44
Open:15.81
Low:15.77
Close:15.95
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:1.06
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:5.48
PE(LYR):-13.03

Loading ...

Novocure receives approval for Optune Pax in Japan

TIPRANKS
·
Yesterday

Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer

THOMSON REUTERS
·
Yesterday

Novocure to Report Q3 2026 Financial Results, Host Conference Call and Webcast

Reuters
·
Yesterday

Novocure to Report Third Quarter 2026 Financial Results

THOMSON REUTERS
·
Yesterday

US Companies Face Rise in Cyber Attacks

Reuters
·
Sep 23

Novocure Director Timothy Scannell Retires from Board

Reuters
·
Sep 09

NovoCure’s PANOVA-4 Trial Hits Completion, Raising New Questions for Pancreatic Cancer Investors

TIPRANKS
·
Sep 05

Novocure CEO to Speak at Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Novocure Announces Upcoming Investor Events

THOMSON REUTERS
·
Sep 02

Oncology Firm Novocure Says Cyberattack Exposed US Patient Records

Reuters
·
Sep 01

Novocure aware of unauthorized access to some information systems

TIPRANKS
·
Sep 01

Novocure Limited: Do not Believe Incident Will Have Material Impact or Likely Material Impact on Financial Condition & Results of Operations

THOMSON REUTERS
·
Sep 01

Novocure - no Access to Medical Devices Obtained; Operations and Systems Fully Functional - SEC Filing

THOMSON REUTERS
·
Sep 01

Novocure - Reports Unauthorized Access to Information Systems in Mid-August 2026 - SEC Filing

THOMSON REUTERS
·
Sep 01

Novocure - Exposed Data Included Internal Patient ID Numbers for over 1,400 U.S. Records - SEC Filing

THOMSON REUTERS
·
Sep 01

Novocure - General Contact Information for Providers and Employees was Exposed - SEC Filing

THOMSON REUTERS
·
Sep 01

Novocure Investigates Unauthorized Access to Some Information Systems

Reuters
·
Sep 01

Is NovoCure (NVCR) A Bargain On Rising Earnings Estimates?

Simply Wall St.
·
Aug 30

Should NovoCure’s (NVCR) Upgraded Momentum Score and Earnings Revisions Require Action From Investors?

Simply Wall St.
·
Aug 22

NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued

Simply Wall St.
·
Aug 11